Britannia Life Sciences Inc. (CSE:BLAB)
Canada
· Delayed Price · Currency is CAD 0.0900
+0.0050 (5.88%)
Dec 4, 2025, 5:26 PM EST
Britannia Life Sciences Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Cash & Equivalents | 0.86 | 7.85 | 1.32 | 2.6 | 1.63 | 0.83 | Upgrade
|
| Cash & Short-Term Investments | 0.86 | 7.85 | 1.32 | 2.6 | 1.63 | 0.83 | Upgrade
|
| Cash Growth | -11.82% | 493.44% | -49.10% | 59.29% | 96.92% | 487.90% | Upgrade
|
| Receivables | 0.3 | 0.23 | 1.21 | 1.6 | 1.79 | 1.69 | Upgrade
|
| Inventory | - | - | 0.18 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.01 | 0.02 | 0.01 | 0.02 | 0.06 | - | Upgrade
|
| Other Current Assets | 1.86 | 1.82 | - | - | - | - | Upgrade
|
| Total Current Assets | 3.03 | 9.93 | 2.73 | 4.22 | 3.48 | 2.51 | Upgrade
|
| Property, Plant & Equipment | 0.11 | 0.14 | 0.72 | 0.45 | 0.55 | 0.7 | Upgrade
|
| Long-Term Investments | 7.17 | 1.54 | 0.73 | 1.27 | 0 | - | Upgrade
|
| Goodwill | - | - | 17.78 | 17.38 | 17.06 | 18.23 | Upgrade
|
| Other Intangible Assets | - | - | 0.3 | 0.23 | 0 | 0 | Upgrade
|
| Total Assets | 10.31 | 11.61 | 22.26 | 23.55 | 21.09 | 21.45 | Upgrade
|
| Accounts Payable | 1.37 | 2.21 | 2.39 | 2.26 | 2.96 | 2.03 | Upgrade
|
| Accrued Expenses | 1.45 | 1.24 | 0.61 | 0.3 | 0.42 | 0.16 | Upgrade
|
| Short-Term Debt | 0.03 | 0.03 | 0.15 | 0.12 | 4.89 | 7.95 | Upgrade
|
| Current Portion of Long-Term Debt | 0.09 | 0.1 | 1.97 | 1.87 | - | - | Upgrade
|
| Current Portion of Leases | 0.08 | 0.07 | 0.11 | 0.06 | 0.05 | 0.04 | Upgrade
|
| Other Current Liabilities | - | - | 5.27 | - | - | - | Upgrade
|
| Total Current Liabilities | 3.02 | 3.65 | 10.5 | 4.6 | 8.32 | 10.19 | Upgrade
|
| Long-Term Debt | 2.17 | 1.54 | 4.76 | 6.29 | 0.12 | 2.36 | Upgrade
|
| Long-Term Leases | 0.07 | 0.11 | 0.3 | 0.08 | 0.13 | 0.19 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.03 | 0.1 | 0.08 | 0.09 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 1.42 | 6.95 | 5.96 | Upgrade
|
| Total Liabilities | 5.26 | 5.31 | 15.59 | 12.49 | 15.61 | 18.79 | Upgrade
|
| Common Stock | 17.11 | 17.11 | 17.11 | 17.11 | 17.07 | 0.44 | Upgrade
|
| Additional Paid-In Capital | 3.41 | 3.41 | 3.41 | 0.16 | 0.16 | 0.16 | Upgrade
|
| Retained Earnings | -14.39 | -13.29 | -17.36 | -11.94 | -16.2 | -0.74 | Upgrade
|
| Comprehensive Income & Other | -1.07 | -0.93 | -0.72 | 1.7 | 0.32 | -0.06 | Upgrade
|
| Total Common Equity | 5.05 | 6.3 | 2.44 | 7.02 | 1.35 | -0.2 | Upgrade
|
| Minority Interest | - | - | 4.23 | 4.04 | 4.13 | 2.86 | Upgrade
|
| Shareholders' Equity | 5.05 | 6.3 | 6.67 | 11.06 | 5.48 | 2.66 | Upgrade
|
| Total Liabilities & Equity | 10.31 | 11.61 | 22.26 | 23.55 | 21.09 | 21.45 | Upgrade
|
| Total Debt | 2.44 | 1.86 | 7.29 | 8.41 | 5.19 | 10.55 | Upgrade
|
| Net Cash (Debt) | -1.58 | 5.99 | -5.96 | -5.81 | -3.56 | -9.72 | Upgrade
|
| Net Cash Per Share | -0.01 | 0.04 | -0.04 | -0.04 | -0.03 | -0.13 | Upgrade
|
| Filing Date Shares Outstanding | 162.25 | 162.25 | 162.25 | 162.25 | 161.9 | 6.47 | Upgrade
|
| Total Common Shares Outstanding | 162.25 | 162.25 | 162.25 | 162.25 | 161.9 | 6.47 | Upgrade
|
| Working Capital | 0.01 | 6.27 | -7.77 | -0.38 | -4.84 | -7.67 | Upgrade
|
| Book Value Per Share | 0.03 | 0.04 | 0.02 | 0.04 | 0.01 | -0.03 | Upgrade
|
| Tangible Book Value | 5.05 | 6.3 | -15.64 | -10.58 | -15.71 | -18.44 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.04 | -0.10 | -0.07 | -0.10 | -2.85 | Upgrade
|
| Machinery | - | - | 0.78 | 0.63 | 0.56 | 0.52 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.